Back to list
Randomized, double-blind, phase III clinical trial of neoadjuvant chemotherapy or a placebo in patients with triple-negative breast cancer followed by adjubant chemotherapy or a placebo
University of North Carolina at Chapel Hill
18 - 99 years
Male and Female participants 18 years and older diagnosed with invasive adenocarcinoma of the breast.